Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 1, 2011, Pages 132-143

  Nagel, Simon ^a,b   Papadakis, Michalis ^a   Chen, Ruoli ^a   Hoyte, Lisa C ^a   Brooks, Keith J ^a   Gallichan, Daniel ^c   Sibson, Nicola R ^c   Pugh, Chris ^a   Buchan, Alastair M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

cerebral blood flow; dimethyloxalylglycine; hypoxia inducible factor; middle cerebral artery occlusion; MRI; neuroprotection prolyl hydroxylases

Indexed keywords

COMPLEMENTARY DNA; DIMETHYLOXALYLGLYCINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENOMIC DNA; GLYCINE DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; NEUROPROTECTIVE AGENT; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GAS ANALYSIS; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CONTROLLED STUDY; DRUG DOSE INCREASE; ENZYME INHIBITION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROMETER; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; WESTERN BLOTTING;

AMINO ACIDS, DICARBOXYLIC; ANIMALS; BEHAVIOR, ANIMAL; BLOOD GAS ANALYSIS; BLOTTING, WESTERN; BRAIN CHEMISTRY; BRAIN ISCHEMIA; CHRONIC DISEASE; GENE EXPRESSION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE IMAGING; MALE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650874284     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.60     Document Type: Article

References (39)

1. Aragones J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M, Dirkx R, Zacchigna S, Lemieux H, Jeoung NH, Lambrechts D, Bishop T, Lafuste P, Diez-Juan A, Harten SK, Van Noten P, De Bock K, Willam C, Tjwa M, Grosfeld A, Navet R, Moons L, Vandendriessche T, Deroose C, Wijeyekoon B, Nuyts J, Jordan B, Silasi-Mansat R, Lupu F, Dewerchin M, Pugh C, Salmon P, Mortelmans L, Gallez B, Gorus F, Buyse J, Sluse F, Harris RA, Gnaiger E, Hespel P, Van Hecke P, Schuit F, Van Veldhoven P, Ratcliffe P, Baes M, Maxwell P, Carmeliet P (2008) Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nature genetics 40:170-80
2. Asikainen TM, Schneider BK, Waleh NS, Clyman RI, Ho WB, Flippin LA, Gunzler V, White CW (2005) Activation of hypoxia-inducible factors in hyperoxia through prolyl 4-hydroxylase blockade in cells and explants of primate lung. Proceedings of the National Academy of Sciences of the United States of America 102:10212-7
3. Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, Chavez JC (2007) Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 27:6320-32
4. Broom KA, Anthony DC, Blamire AM, Waters S, Styles P, Perry VH, Sibson NR (2005) MRI reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MS-like lesions in rat brain. J Cereb Blood Flow Metab 25:204-16
5. Bruick RK, McKnight SL (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science (New York, NY) 294:1337-40
6. Buchan AM, Slivka A, Xue D (1992) The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain research 574:171-7
7. Chen W, Jadhav V, Tang J, Zhang JH (2008) HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiology of disease 31:433-41
8. Cummins EP, Seeballuck F, Keely SJ, Mangan NE, Callanan JJ, Fallon PG, Taylor CT (2008) The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134:156-65
9. Digicaylioglu M, Lipton SA (2001) Erythropoietinmediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412:641-7
10. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Jahnig P, Herrmann M, Knauth M, Bahr M, Heide W, Wagner A, Schwab S, Reichmann H, Schwendemann G, Dengler R, Kastrup A, Bartels C (2009) Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke; a journal of cerebral circulation 40:e647-56
11. Endres M, Laufs U, Liao JK, Moskowitz MA (2004) Targeting eNOS for stroke protection. Trends in neurosciences 27:283-9
12. Fan X, Heijnen CJ, van der Kooij MA, Groenendaal F, van Bel F (2009) The role and regulation of hypoxiainducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury. Brain Res Rev 62:99-108
13. Fu R, Zhao ZQ, Zhao HY, Zhao JS, Zhu XL (2006) Expression of heme oxygenase-1 protein and messenger RNA in permanent cerebral ischemia in rats. Neurological research 28:38-45
14. Garcia JH, Liu KF, Ho KL (1995) Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke; a journal of cerebral circulation 26:636-42; discussion 43
15. Hewitson KS, McNeill LA, Schofield CJ (2004) Modulating the hypoxia-inducible factor signaling pathway: applications from cardiovascular disease to cancer. Current pharmaceutical design 10:821-33
16. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (New York, NY) 292:468-72
17. Kilic E, Kilic U, Wang Y, Bassetti CL, Marti HH, Hermann DM (2006) The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF0s neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. Faseb J 20:1185-7
18. Kim SG (1995) Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med 34:293-301
19. Laudenbach V, Fontaine RH, Medja F, Carmeliet P, Hicklin DJ, Gallego J, Leroux P, Marret S, Gressens P (2007) Neonatal hypoxic preconditioning involves vascular endothelial growth factor. Neurobiology of disease 26:243-52
20. Lo EH, Hara H, Rogowska J, Trocha M, Pierce AR, Huang PL, Fishman MC, Wolf GL, Moskowitz MA (1996) Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression. Stroke; a journal of cerebral circulation 27:1381-5
21. Loenarz C, Schofield CJ (2008) Expanding chemical biology of 2-oxoglutarate oxygenases. Nature Chemical Biology 4:152-6
22. Marchal G, Young AR, Baron JC (1999) Early postischemic hyperperfusion: pathophysiologic insights from positron emission tomography. J Cereb Blood Flow Metab 19:467-82
23. Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B, Tian YM, Lanahan AA, Pollard P, Ruiz de Almodovar C, De Smet F, Vinckier S, Aragones J, Debackere K, Luttun A, Wyns S, Jordan B, Pisacane A, Gallez B, Lampugnani MG, Dejana E, Simons M, Ratcliffe P, Maxwell P, Carmeliet P (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136:839-51
24. Milkiewicz M, Pugh CW, Egginton S (2004) Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice. The Journal of physiology 560:21-6
25. Nagasawa H, Kogure K (1989) Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke; a Journal of Cerebral Circulation 20:1037-43
26. Nagel S, Talbot NP, Mecinovic J, Smith TG, Buchan AM, Schofield CJ (2009) Therapeutic Manipulation of the HIF Hydroxylases. Antioxidants & Redox Signaling 12:481-501
27. Natarajan R, Salloum FN, Fisher BJ, Smithson L, Almenara J, Fowler AA III (2009) Prolyl hydroxylase inhibition attenuates post-ischemic cardiac injury via induction of endoplasmic reticulum stress genes. Vascul Pharmacol 51:110-8
28. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA III, Kukreja RC (2005) HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. American journal of physiology 289:H542-8
29. Ordidge RJ, Helpern JA, Qing ZX, Knight RA, Nagesh V (1994) Correction of motional artifacts in diffusionweighted MR images using navigator echoes. Magnetic resonance imaging 12:455-60
30. Pan J, Konstas AA, Bateman B, Ortolano GA, Pile-Spellman J (2007) Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology 49:93-102
31. Schneider M, van Geyte K, Fraisl P, Kiss J, Aragones J, Mazzone M, Mairbaurl H, Debock K, Ho Jeoung N, Mollenhauer M, Georgiadou M, Bishop T, Roncal C, Sutherland A, Jordan B, Gallez B, Weitz J, Harris RA, Maxwell P, Baes M, Ratcliffe P, Carmeliet P (2010) Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/referpusion injury. Gastroenterology 138:1143-54.e1-2
32. Semenza GL (2001) Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatric research 49:614-7
33. Semenza GL (2007) Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. The Biochemical journal 405:1-9
34. Siddiq A, Ayoub IA, Chavez JC, Aminova L, Shah S, LaManna JC, Patton SM, Connor JR, Cherny RA, Volitakis I, Bush AI, Langsetmo I, Seeley T, Gunzler V, Ratan RR (2005) Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. The Journal of biological chemistry 280:41732-43
35. Sun FY, Guo X (2005) Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. Journal of neuroscience research 79:180-4
36. Takeda K, Cowan A, Fong GH (2007) Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 116:774-81
37. van der Kooij MA, Groenendaal F, Kavelaars A, Heijnen CJ, van Bel F (2008) Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia. Brain Res Rev 59:22-33
38. Wang Y, Jin K, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA (2007) VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration. Journal of Neuroscience Research 85:740-7
39. Webb JD, Coleman ML, Pugh CW (2009) Hypoxia, hypoxiainducible factors (HIF), HIF hydroxylases and oxygen sensing. Cell Mol Life Sci 66:3539-54